Hologic Inc (NASDAQ:HOLX)

76.23
Delayed Data
As of May 13
 0.00 / 0.00%
Today’s Change
60.10
Today|||52-Week Range
81.04
-0.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$19.0B

Company Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment comprises products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Contact Information

Hologic, Inc.
250 Campus Drive
Marlborough Massachusetts 01752
P:(508) 263-2900
Investor Relations:
(858) 410-8588

Employees

Shareholders

Mutual fund holders62.97%
Other institutional34.54%
Individual stakeholders3.77%

Top Executives

Stephen P. MacMillanChairman, President & Chief Executive Officer
Karleen Marie ObertonChief Financial Officer
Jay A. SteinChairman-Emeritus, Chief Technology Officer & SVP
Marci J. LernerTreasurer, Vice President
Jan VerstrekenGroup President-International